Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x

VIATRIS Aktie

 >VIATRIS Aktienkurs 
7.71 EUR    +3.2%    (Tradegate)
Ask: 7.708 EUR / 3900 Stück
Bid: 7.67 EUR / 3920 Stück
Tagesumsatz: 15892 Stück
Realtime Kurs von 8 bis 22 Uhr!
VIATRIS Aktie über LYNX handeln
>VIATRIS Performance
1 Woche: -0,6%
1 Monat: -1,9%
3 Monate: -11,9%
6 Monate: -35,6%
1 Jahr: -19,9%
laufendes Jahr: -35,1%
>VIATRIS Aktie
Name:  VIATRIS INC. O.N.
Land:  USA
Sektor:  Gesundheit
ISIN/ Wkn:  US92556V1061 / A2QAME
Symbol/ Ticker:  VIA (Frankfurt) / VTRS (NASDAQ)
Kürzel:  FRA:VIA, ETR:VIA, VIA:GR, NASDAQ:VTRS
Index:  S&P500
Webseite:  https://www.viatris.com/
Marktkapitalisierung:  9030 Mio. EUR
Umsatz:  12406.82 Mio. EUR
EBITDA:  3653.65 Mio. EUR
Gewinn je Aktie:  -2.39 EUR
Schulden:  12519.37 Mio. EUR
Liquide Mittel:  865.79 Mio. EUR
Umsatz-/ Gewinnwachstum:  -11.2% / -
KGV/ KGV lG:  28.53 / 4.08
KUV/ KBV/ PEG:  0.74 / 0.67 / 0.15
Gewinnm./ Eigenkapitalr.:  -26.45% / -21.25%
Dividende je Aktie:  0.44 EUR
Dividendenrendite/ -schätzung:  5.7% / 5.48%
Div. Historie:  23.05.25 - 0.10637€
10.03.25 - 0.11077€
>weitere anzeigen...
Insiderhandel:  -
Suchwörter:  VIATRIS
Letzte Datenerhebung:  22.06.25
>VIATRIS Eigentümer
Aktien: 1170 Mio. St.
f.h. Aktien: 1170 Mio. St.
Insider Eigner: 0.54%
Instit. Eigner: 85.11%
>VIATRIS Peer Group

 
12.06.25 - 22:33
 Viatris to Report Second Quarter 2025 Financial Results on August 7, 2025 (PR Newswire)
 
PITTSBURGH, June 12, 2025 /PRNewswire/ -- Viatris Inc. (Nasdaq: VTRS) will report second quarter 2025 financial results on Thursday, August 7, 2025. Company executives will host a webcast at 8:30 a.m. ET on the same date to discuss the results. Investors and the general public are invited......
10.06.25 - 12:00
 Zacks Industry Outlook Highlights Sandoz, Teva Pharmaceuticals and Viatris (Zacks)
 
SDZNY, TEVA, and VTRS show resilience with strong biosimilar pipelines and margin strategies amid industry headwinds....
09.06.25 - 16:30
 3 Generic Drug Stocks to Watch Amid Pricing Pressure & Tariff Threats (Zacks)
 
Sandoz, Teva and Viatris are navigating generic drug pricing pressure with scale, complex generics and cost cuts....
06.06.25 - 17:27
 Teva, Amneal rated Buy, Viatris Neutral as Goldman Sachs reviews generics space (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
02.06.25 - 22:33
 Viatris sees positive top-line phase 3 results for night driving impairment asset (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
02.06.25 - 18:01
 Viatris Inc. (VTRS) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit (PR Newswire)
 
LOS ANGELES, June 2, 2025 /PRNewswire/ -- Glancy Prongay & Murray LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against Viatris Inc. ("Viatris" or the "Company") (NASDAQ: VTRS). IF YOU SUFFERED A LOSS ON YOUR VIATRIS......
02.06.25 - 15:33
 VTRS Investors Have Opportunity to Lead Viatris Inc. Securities Fraud Lawsuit with the Schall Law Firm (PR Newswire)
 
LOS ANGELES, June 2, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Viatris Inc. ("Viatris" or "the Company") (NASDAQ: VTRS) for violations of §§10(b) and 20(a) of the Securities Exchange Act of......
02.06.25 - 15:12
 DEADLINE TOMORROW: Berger Montague Advises Viatris (NASDAQ: VTRS) Investors to Inquire About a Securities Fraud Class Action by June 3, 2025 (PR Newswire)
 
PHILADELPHIA, June 2, 2025 /PRNewswire/ -- Berger Montague PC advises investors that a securities class action lawsuit has been filed against Viatris Inc. ("Viatris" or the "Company") (NASDAQ: VTRS) on behalf of purchasers of Viatris securities between August 8, 2024 through February 26,......
02.06.25 - 14:42
 Viatris Reports Positive Top-line Results From LYNX-2 Phase 3 Trial With MR-142 (AFX)
 
WASHINGTON (dpa-AFX) - Viatris (VTRS) reported positive top-line results from LYNX-2, a Phase 3 trial evaluating MR-142 in treating significant, chronic night driving impairment in keratorefractiv......
02.06.25 - 14:06
 Viatris Announces Positive Top-Line Results from Phase 3 LYNX-2 Trial of MR-142 in Keratorefractive Patients With Visual Disturbances Under Mesopic, Low-Contrast Conditions (PR Newswire)
 
MR-142 Achieved Primary Endpoint of ≥15-letter (≥3-line) Gain in Mesopic Low Contrast Distance Visual Acuity in Comparison to Placebo Results Showed Patient-Reported Functional Benefit in Treating Significant Chronic Night Driving Impairment in Keratorefractive Patients With Reduced......
01.06.25 - 20:06
 Viatris Deadline: VTRS Investors with Losses in Excess of $100K Have Opportunity to Lead Viatris Inc. Securities Fraud Lawsuit (PR Newswire)
 
NEW YORK, June 1, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Viatris Inc. (NASDAQ: VTRS) between August 8, 2024 and February 26, 2025, both dates inclusive (the "Class Period"), of the important June 3, 2025 lead......
01.06.25 - 16:01
 INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Viatris Inc. of Class Action Lawsuit and Upcoming Deadlines - VTRS (PR Newswire)
 
NEW YORK, June 1, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Viatris, Inc. ("Viatris" or the "Company") (NASDAQ: VTRS). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW),......
31.05.25 - 14:48
 SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Viatris (PR Newswire)
 
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Viatris To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Viatris between August 8, 2024 and February 26, 2025 and would like to......
30.05.25 - 11:51
 Class Action Filed Against Viatris Inc. (VTRS) - June 3, 2025 Deadline to Join - Contact Levi & Korsinsky (PR Newswire)
 
NEW YORK, May 30, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Viatris Inc. ("Viatris" or the "Company") (NASDAQ: VTRS) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Viatris investors who were adversely......
29.05.25 - 11:48
 Viatris Inc. Sued for Securities Law Violations - Contact The Gross Law Firm Before June 3, 2025 to Discuss Your Rights - VTRS (PR Newswire)
 
NEW YORK, May 29, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Viatris Inc. (NASDAQ: VTRS). Shareholders who purchased shares of VTRS during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.......
29.05.25 - 02:24
 Kuehn Law Encourages Investors of Viatris Inc. to Contact Law Firm (PR Newswire)
 
NEW YORK, May 28, 2025 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Viatris Inc. (NASDAQ: VTRS) breached their fiduciary duties to shareholders. According to a federal securities lawsuit, Insiders at Viatris......
28.05.25 - 18:01
 Viatris Inc. (VTRS) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit (PR Newswire)
 
BENSALEM, Pa., May 28, 2025 /PRNewswire/ -- The Law Offices of Howard G. Smith announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Viatris Inc. ("Viatris" or the "Company") (NASDAQ: VTRS). IF YOU ARE AN INVESTOR WHO......
28.05.25 - 17:24
 VTRS Investors Have Opportunity to Lead Viatris Inc. Securities Fraud Lawsuit with the Schall Law Firm (PR Newswire)
 
LOS ANGELES, May 28, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Viatris Inc. ("Viatris" or "the Company") (NASDAQ: VTRS) for violations of §§10(b) and 20(a) of the Securities Exchange Act of......
28.05.25 - 15:09
 CLASS ACTION DEADLINE APPROACHING: Berger Montague Advises Viatris (NASDAQ: VTRS) Investors to Inquire About a Securities Fraud Class Action by June 3, 2025 (PR Newswire)
 
PHILADELPHIA, May 28, 2025 /PRNewswire/ -- Berger Montague PC advises investors that a securities class action lawsuit has been filed against VIATRIS INC. ("Viatris" or the "Company") (NASDAQ: VTRS) on behalf of purchasers of Viatris securities between August 8, 2024 through February 26,......
27.05.25 - 22:39
 Viatris Deadline: VTRS Investors Have Opportunity to Lead Viatris Inc. Securities Fraud Lawsuit (PR Newswire)
 
NEW YORK, May 27, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Viatris Inc. (NASDAQ: VTRS) between August 8, 2024 and February 26, 2025, both dates inclusive (the "Class Period"), of the important June 3, 2025 lead......
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Ein dummer Bodybuilder redet Maskulatur. - Dr. Fritz P. Rinnhofer
Partner:    >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!